Showing results (301-310 of 312) with videos related to
Sort By:
Pageof 32
Nature Medicine|August 11, 2018
Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibitionGabrielle S Wong, Jin Zhou, Jie Bin Liu, et al.Nature Communications|April 8, 2017
Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2Haikuo Zhang, Christine Fillmore Brainson, Shohei Koyama, et al.Pancreas|April 9, 2021
Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative ReviewBarbara Kenner, Suresh T Chari, David Kelsen, et al.Nature Communications|June 10, 2017
Erratum: Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2Haikuo Zhang, Christine Fillmore Brainson, Shohei Koyama, et al.Gastroenterology|December 9, 2021
The Origin and Contribution of Cancer-Associated Fibroblasts in Colorectal CarcinogenesisHiroki Kobayashi, Krystyna A Gieniec, Tamsin R M Lannagan, et al.Gastroenterology|November 16, 2020
The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal CarcinogenesisHiroki Kobayashi, Krystyna A Gieniec, Josephine A Wright, et al.Nature Genetics|May 11, 2021
Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependenceZhong Wu, Jin Zhou, Xiaoyang Zhang, et al.Cancer Discovery|December 15, 2015
Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic CancerNicholas J Roberts, Alexis L Norris, Gloria M Petersen, et al.Nature Genetics|October 6, 2009
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomasAdam J Bass, Hideo Watanabe, Craig H Mermel, et al.Cell|January 17, 2015
Gremlin 1 identifies a skeletal stem cell with bone, cartilage, and reticular stromal potentialDaniel L Worthley, Michael Churchill, Jocelyn T Compton, et al.Pageof 32